Search for Clinical Trial Results

Sponsored By

ACTH-Secreting Pituitary Adenoma - 32 Studies Found

Status Study
Recruiting Study Name: Treatment of Cushing's Disease With R-roscovitine
Condition: Cushings Disease
Date: 2014-05-21
Interventions: Drug: R-roscovitine See Arm Description Other Names:
Recruiting Study Name: Safety and Efficacy of LCI699 for the Treatment of Patients With Cushing's Disease
Condition: Cushing's Disease
Date: 2014-06-17
Interventions: Drug: LCI699
Active, not recruiting Study Name: Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease
Condition: Cushing's Disease
Date: 2013-06-10
Interventions: Drug: Pasireotide with or without cabergoline The trial consists of Pasireotide-untreated patients will
Recruiting Study Name: Cushing's Disease Complications
Condition: Cushing's Disease
Date: 2015-07-20
Interventions: Other: Exams and questionnaires Blood sample 24hrs urinary cortisol and salivary cortisol, urinary labst
Completed Study Name: Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease
Condition: Cushing Disease
Date: 2005-09-13
Interventions: Drug: Pasireotide
Completed Study Name: Efficacy and Safety of Pasireotide Administered Monthly in Patients With Cushing's Disease
Condition: Cushing's Disease
Date: 2011-06-14
Interventions:
  • Drug: SOM230 LAR 30 mg startin
Recruiting Study Name: Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease
Condition: Cushings Disease
Date: 2014-09-26
Interventions: Drug: SOM230
Completed Study Name: Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease
Condition: Cushing's Disease
Date: 2007-02-09
Interventions: Drug: Pasireotide
Active, not recruiting Study Name: Safety and Efficacy of LCI699 in Cushing's Disease Patients.
Condition: Cushing's Disease
Date: 2011-04-06
Interventions: Drug: LCI699
Completed Study Name: An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease.
Condition: Cushing's Disease
Date: 2012-04-12
Interventions: Drug: Pasireotide sub-cutaneous formulation Pasireotide will be administered twice a day until pasireoti
Next >>>